Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2021-10-01 00:00:00 ET · period of report 2021-09-01 · accession 0001209191-21-058517 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-10-01 | 2021-09-01+ | CPIX | KAZIMI A J | COB, CEO, Dir, 10% | P - Purchase | $2.83 | +315 | 5.77M | +0.0% | +$891.15 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-07 | P | A | 15 | $2.79 | 5,769,204 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 2 | Common | Common Stock | 2021-09-08 | P | A | 15 | $2.89 | 5,769,219 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 3 | Common | Common Stock | 2021-09-09 | P | A | 15 | $2.77 | 5,769,234 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 4 | Common | Common Stock | 2021-09-10 | P | A | 15 | $2.78 | 5,769,249 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 5 | Common | Common Stock | 2021-09-13 | P | A | 15 | $2.96 | 5,769,264 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 6 | Common | Common Stock | 2021-09-14 | P | A | 15 | $3.02 | 5,769,279 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 7 | Common | Common Stock | 2021-09-15 | P | A | 15 | $2.86 | 5,769,294 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 8 | Common | Common Stock | 2021-09-16 | P | A | 15 | $2.91 | 5,769,309 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 9 | Common | Common Stock | 2021-09-17 | P | A | 15 | $2.85 | 5,769,324 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 10 | Common | Common Stock | 2021-09-20 | P | A | 15 | $2.82 | 5,769,339 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 11 | Common | Common Stock | 2021-09-21 | P | A | 15 | $2.81 | 5,769,354 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 12 | Common | Common Stock | 2021-09-22 | P | A | 15 | $2.76 | 5,769,369 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 13 | Common | Common Stock | 2021-09-23 | P | A | 15 | $2.75 | 5,769,384 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 14 | Common | Common Stock | 2021-09-24 | P | A | 15 | $2.74 | 5,769,399 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 15 | Common | Common Stock | 2021-09-02 | P | A | 15 | $2.88 | 5,769,174 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 16 | Common | Common Stock | 2021-09-01 | P | A | 15 | $2.88 | 5,766,159 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 17 | Common | Common Stock | 2021-09-27 | P | A | 15 | $2.79 | 5,769,414 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 18 | Common | Common Stock | 2021-09-28 | P | A | 15 | $2.76 | 5,769,429 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 19 | Common | Common Stock | 2021-09-29 | P | A | 15 | $2.82 | 5,769,444 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 20 | Common | Common Stock | 2021-09-30 | P | A | 15 | $2.72 | 5,769,459 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 21 | Common | Common Stock | 2021-09-03 | P | A | 15 | $2.85 | 5,769,189 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |